Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 34
17
Diseases
68
Unique genes
0.169
Avg. similarity score
Neural tube defects, folate-sensitive
Most-connected disease (9 links)
Disease
Searched: Methylmalonic acidemia
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Methylmalonic acidemia
Neural tube defects, folate-sensitive
Intracellular cobalamin metabolism disorder
Homocystinuria with megaloblastic anemia
Hyperhomocysteinemia
methylcobalamin deficiency type cblG
Anencephaly
Aprosencephaly
Malnutrition
methylcobalamin deficiency type cblE
Cobalamin c disease
methylmalonic acidemia with homocystinuria, type cblJ
Hematologic disease
methylmalonic aciduria and homocystinuria
Advanced sleep phase syndrome
Alpha-mannosidosis
methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Neural tube defects, folate-sensitive | 9 | 9 | 4 |
| Intracellular cobalamin metabolism disorder | 8 | 8 | 9 |
| Homocystinuria with megaloblastic anemia | 7 | 7 | 4 |
| Hyperhomocysteinemia | 6 | 6 | 13 |
| Methylmalonic acidemia | 6 | 6 | 27 |
| methylcobalamin deficiency type cblG | 5 | 5 | 1 |
| Anencephaly | 4 | 4 | 9 |
| Aprosencephaly | 4 | 4 | 4 |
| Malnutrition | 4 | 4 | 3 |
| methylcobalamin deficiency type cblE | 4 | 4 | 1 |
| Cobalamin c disease | 3 | 3 | 7 |
| methylmalonic acidemia with homocystinuria, type cblJ | 3 | 3 | 1 |
| Hematologic disease | 2 | 2 | 18 |
| methylmalonic aciduria and homocystinuria | 2 | 2 | 2 |
| Advanced sleep phase syndrome | 1 | 1 | 3 |
| Alpha-mannosidosis | 1 | 1 | 1 |
| methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MTR | 7 / 17 | Hematologic disease, Homocystinuria with megaloblastic anemia, Hyperhomocysteinemia, Intracellular cobalamin metabolism disorder and 3 more |
| MTRR | 7 / 17 | Anencephaly, Aprosencephaly, Homocystinuria with megaloblastic anemia, Hyperhomocysteinemia and 3 more |
| MTHFR | 5 / 17 | Anencephaly, Hematologic disease, Hyperhomocysteinemia, Malnutrition and 1 more |
| ABCD4 | 4 / 17 | Cobalamin c disease, Intracellular cobalamin metabolism disorder, Methylmalonic acidemia, methylmalonic acidemia with homocystinuria, type cblJ |
| MMADHC | 4 / 17 | Cobalamin c disease, Homocystinuria with megaloblastic anemia, Intracellular cobalamin metabolism disorder, Methylmalonic acidemia |
| HCFC1 | 3 / 17 | Cobalamin c disease, Intracellular cobalamin metabolism disorder, Methylmalonic acidemia |
| LMBRD1 | 3 / 17 | Cobalamin c disease, Intracellular cobalamin metabolism disorder, Methylmalonic acidemia |
| MMACHC | 3 / 17 | Cobalamin c disease, Intracellular cobalamin metabolism disorder, Methylmalonic acidemia |
| THAP11 | 3 / 17 | Intracellular cobalamin metabolism disorder, Methylmalonic acidemia, methylmalonic aciduria and homocystinuria |
| ZNF143 | 3 / 17 | Intracellular cobalamin metabolism disorder, Methylmalonic acidemia, methylmalonic aciduria and homocystinuria |
| CBS | 2 / 17 | Hyperhomocysteinemia, Malnutrition |
| MAN2B1 | 2 / 17 | Alpha-mannosidosis, Methylmalonic acidemia |
| MCEE | 2 / 17 | Methylmalonic acidemia, methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency |
| NUAK2 | 2 / 17 | Anencephaly, Aprosencephaly |
| PER3 | 2 / 17 | Advanced sleep phase syndrome, Homocystinuria with megaloblastic anemia |
| PRDX1 | 2 / 17 | Cobalamin c disease, Methylmalonic acidemia |
| RPGRIP1L | 2 / 17 | Anencephaly, Aprosencephaly |
| TRIM36 | 2 / 17 | Anencephaly, Aprosencephaly |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cobalamin transport and metabolism | KEGG | 14 / 18 | 137× | 2.51e-29 | 6.32e-26 ✓ sig. |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | Reactome | 10 / 21 | 84.1× | 5.70e-18 | 2.91e-15 ✓ sig. |
| Propionyl-CoA catabolism | Reactome | 3 / 5 | 106× | 1.72e-6 | 7.80e-5 ✓ sig. |
| One carbon pool by folate | KEGG | 5 / 38 | 23.2× | 2.18e-6 | 9.57e-5 ✓ sig. |
| Vitamin digestion and absorption | KEGG | 4 / 26 | 27.2× | 1.28e-5 | 4.19e-4 ✓ sig. |
| Legionellosis | KEGG | 5 / 56 | 15.8× | 1.53e-5 | 4.86e-4 ✓ sig. |
| Folate transport and metabolism | KEGG | 4 / 31 | 22.8× | 2.64e-5 | 7.66e-4 ✓ sig. |
| Defective MMAA causes methylmalonic aciduria type cblA | Reactome | 2 / 2 | 177× | 3.16e-5 | 8.85e-4 ✓ sig. |
| Defective MUT causes methylmalonic aciduria mut type | Reactome | 2 / 2 | 177× | 3.16e-5 | 8.85e-4 ✓ sig. |
| Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD | Reactome | 2 / 2 | 177× | 3.16e-5 | 8.85e-4 ✓ sig. |
| Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE | Reactome | 2 / 2 | 177× | 3.16e-5 | 8.85e-4 ✓ sig. |
| Defective MTR causes methylmalonic aciduria and homocystinuria type cblG | Reactome | 2 / 2 | 177× | 3.16e-5 | 8.85e-4 ✓ sig. |
| Detoxification of Reactive Oxygen Species | Reactome | 4 / 34 | 20.8× | 3.84e-5 | 1.04e-3 ✓ sig. |
| Influenza A | KEGG | 7 / 173 | 7.1× | 5.27e-5 | 1.35e-3 ✓ sig. |
| Peroxisome | KEGG | 5 / 83 | 10.6× | 1.03e-4 | 2.33e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cobalamin metabolic process | GO:0009235 | 7 / 9 | 214× | 2.20e-16 | 1.91e-13 ✓ sig. |
| homocysteine metabolic process | GO:0050667 | 5 / 10 | 137× | 1.36e-10 | 3.78e-8 ✓ sig. |
| methionine biosynthetic process | GO:0009086 | 4 / 11 | 99.9× | 5.19e-8 | 7.00e-6 ✓ sig. |
| methionine metabolic process | GO:0006555 | 3 / 6 | 137× | 9.15e-7 | 7.77e-5 ✓ sig. |
| regulation of stress-activated MAPK cascade | GO:0032872 | 3 / 10 | 82.4× | 5.43e-6 | 3.27e-4 ✓ sig. |
| response to nutrient levels | GO:0031667 | 5 / 79 | 17.4× | 1.01e-5 | 5.33e-4 ✓ sig. |
| folic acid metabolic process | GO:0046655 | 3 / 15 | 55.0× | 2.03e-5 | 9.24e-4 ✓ sig. |
| response to reactive oxygen species | GO:0000302 | 3 / 20 | 41.2× | 5.03e-5 | 1.84e-3 ✓ sig. |
| non-motile cilium assembly | GO:1905515 | 4 / 57 | 19.3× | 5.48e-5 | 1.96e-3 ✓ sig. |
| tumor necrosis factor-mediated signaling pathway | GO:0033209 | 4 / 60 | 18.3× | 6.71e-5 | 2.29e-3 ✓ sig. |
| response to amino acid | GO:0043200 | 3 / 22 | 37.5× | 6.75e-5 | 2.30e-3 ✓ sig. |
| response to L-ascorbic acid | GO:0033591 | 2 / 4 | 137× | 7.79e-5 | 2.57e-3 ✓ sig. |
| response to isolation stress | GO:0035900 | 2 / 4 | 137× | 7.79e-5 | 2.57e-3 ✓ sig. |
| S-adenosylmethionine metabolic process | GO:0046500 | 2 / 4 | 137× | 7.79e-5 | 2.57e-3 ✓ sig. |
| homocysteine catabolic process | GO:0043418 | 2 / 4 | 137× | 7.79e-5 | 2.57e-3 ✓ sig. |